Interleukin‐33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells
Ivan Jovanović(University of Kragujevac), Miodrag L. Lukić(University of Kragujevac), Nada Pejnović(University of Kragujevac), Nebojša Arsenijević(University of Kragujevac), Gordana Radosavljević(University of Kragujevac), Jelena Pantić(University of Kragujevac), Marija Milovanović(University of Kragujevac)
Cited by 326
Related Papers
IL-1 family nomenclature
|Nature Immunology|2010|341
<scp>IL</scp>‐33 attenuates EAE by suppressing <scp>IL</scp>‐17 and <scp>IFN</scp>‐γ production and inducing alternatively activated macrophages
|European Journal of Immunology|2012|304
Concise Review: Mesenchymal Stem Cell Treatment of the Complications of Diabetes Mellitus
|Stem Cells|2010|286
IL-33/ST2 axis in inflammation and immunopathology
|Immunologic Research|2012|259
Prevalence of diabetes mellitus and its complications in a population-based sample in Al Ain, United Arab Emirates
|Diabetes Research and Clinical Practice|2007|212